Liver transplantation in metabolic diseases: Current status

Pediatric Transplantation

Volumn 6, Issue 5, 2002, Pages 361-363

  Burdelski, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BENZOIC ACID; BILIRUBIN; BLOOD CLOTTING FACTOR 8 CONCENTRATE; CYCLOHEXANE DERIVATIVE; NITROTRIFLUOROMETHYLBENZOYLCYCLOHEXANEDIONE; OXALIC ACID; PHENOBARBITAL; PYRIDOXINE; TYROSINE; UNCLASSIFIED DRUG;

ACIDEMIA; BRAIN EDEMA; BRAIN INJURY; CRIGLER NAJJAR SYNDROME; DIET RESTRICTION; EDITORIAL; GENE THERAPY; HUMAN; HYPEROXALURIA; KERNICTERUS; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; METABOLIC DISORDER; NIEMANN PICK DISEASE; OXALOSIS 1; PHOTOTHERAPY; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SECOND CANCER; UREA CYCLE;

CHILD; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; METABOLISM, INBORN ERRORS;

EID: 0036802617     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2002.2e031.x     Document Type: Editorial

References (31)

1. Kelly DA. Current results and evolving indications for pediatric liver transplantation. J Pediatr Gastroenterol Nutr 1998: 27: 214-221.
2. Burdelsk M, Nolkemper D, Ganschow R, et al. Liver transplantation in children. Long-term outcome and quality of life. Eur J Pediatr 1999: 158 (Suppl. 2): S34-S42.
3. Ganschow R, Broering DC, Stuerenburg I, Hellwege HH, Rogiers X. First experience with basiliximab in pediatric liver graft recipients. Pediatr Transpl 2001: 5: 353-358.
4. Ganschow R, Nolkemper D, Helmke K, et al. Intensive care management after pediatric liver transplantation: A single center experience. Pediatr Transpl 2000: 4: 272-279.
5. Burdelski M, Rodeck B, Latta A. Treatment of inherited metabolic disorders by liver transplantation. J Inherit Metab Dis 1991: 14: 604-618.
6. Mohan N, McKiernan P, Preece MA, et al. Indications and outcome of liver transplantation in tyrosinemia type 1. Eur J Pediatr 1999: 158 (Suppl. 2): S49-S54.
7. Sokal EM, Sokol R, Cornier V, et al. Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 1999: 158 (Suppl. 2): S81-S84.
8. Sigurdsson L, Reyes J, Kocoshis SA, et al. Neonatal hemochromatosis: Outcome of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 1998: 26: 85-89.
9. Sternlieb J. Perspectives on Wilson's disease. Hepatology 1990: 12: 1234-1239.
10. Kelly DA. Editorial. Liver transplantation: To do or not to do. Pediatr Transpl 2000: 4: 170-172.
11. Nemeth A. Liver transplantation in α1-antitrypsin deficiency. Eur J Pediatr 1999: 154 (Suppl. 2): S85-S88.
12. Matern D, Starzl TE, Arnaout W, et al. Liver transplantation for glycogen storage disease types I, III and IV. Eur J Pediatr 1999: 158 (Suppl. 2): S43-S48.
13. Sally R, O'Grady J, Williams R. Transplantation in primary biliary cirrhosis. J Gastroenterol Hepatol 1991: 6: 558-562.
14. Lewis JH, Bontempo FA, Spiro JA, Ragni MV, Starzl TE. Liver transplantation in a hemophiliac. N Engl J Med 1985: 312: 1189-1190.
15. Saudubray JM, Touati G, Delonlay P, et al. Liver transplantation in urea cycle disorders. Eur J Pediatr 1999: 158 (Suppl. 2): S55-S59.
16. Saudubray JM, Touati G, Delonlay P, et al. Liver transplantation in propionic acidemia. Eur J Pediatr 1999: 158 (Suppl. 2): S65-S70.
17. Hoff W, Van't McKiernan P, Surtees RAH, Leonard JV. Liver transplantation for methylmalonic acidemia. Eur J Pediatr 1999: 158 (Suppl. 2): S70-S74.
18. Wendel U, Saudubray JM, Bodner A, Schadewaldt P. Liver transplantation in maple syrup urine disease. Eur J Pediatr 1999: 158 (Suppl. 2): S60-S64.
19. Jansen PLM. Diagnosis and management of Crigler-Najjar syndrome. Eur J Pediatr 1999: 158 (Suppl. 2): S89-S94.
20. Cochat P, Saulier JM, Nogueira PL, et al. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr 1999: 158 (Suppl. 2): S75-S80.
21. Nolkemper D, Kemper MJ, Burdelski M, et al. Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1. Pediatr Transpl 2000: 4: 177-181.
22. Leumann E, Hoppe B. Editorial: Pre-emptive liver transplantation in primary hyperoxaluria type 1: a controversial issue. Pediatr Transpl 2000: 4: 1611-1614.
23. Holme E, Lindquist S. Diagnosis and management of tyrosinemia type 1. Curr Opin Pediatr 1995: 7: 723-726.
24. Alshak NS, Cocjiin J, Poduta L, et al. Hepatocellular carcinoma in glycogen storage disease type IV. Arch Pathol Lab Med 1994: 118: 88-91.
25. Coire JC, Qizilbash AH, Castelli MF. Hepatic adenoma in type 1 glycogen storage disease. Arch Pathol Lab Med 1987: 111: 166-169.
26. Govindarajan S, Ashcavai M, Peters RL. α1-antitrypsin phenotypes in hepatocellular carcinoma. Hepatology 1981: 1: 628-631.
27. Siersema PD, Ten Kate FJW, Mulder PGH, Wilson JHP. Hepatocellular carcinoma in porphyria cutanea tarda: Frequency and factors related to its occurrence. Liver 1992: 12: 56-61.
28. Polio J, Enriquez RE, Chow A, Wood WM, Herbury CE. Hepatocellular carcinoma in Wilson's disease: Case report and review of the literature. J Clin Gastroenterol 1989: 11: 220-224.
29. Niederau C, Fischer R, Pürschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996: 110: 1107-1119.
30. Kayler LK, Merion RM, Lee S, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transpl 2002: 6: 295-300.
31. Couetil JP, Soubrane O, Houssin DP, et al. Combined heart-lung-liver, double-lung-liver and isolated liver transplantation for cystic fibrosis in children. Transpl Int 1997: 10: 33-39.